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Abstract
The cells of our body comprise calcitriol (1,25(OH) vitamin D2), the active form 
of vitamin D, an integral biological substance that has an impact on a large number 
of biological processes. While high prevalence of vitamin D deficiency is detected 
in population worldwide, the reports from sun-soaked countries like India are also 
alarming to note that the deficiency of vitamin D as high as 70 to 90% is observed 
leading to several chronic diseases in the majority of people. Deficiency of vitamin 
D is observed not only because of low levels of vitamin D in the diet, less exposure 
to sunlight, reduced cutaneous vitamin D synthesis, but also due to consumption 
of particular medicines, undue alcohol intake, and tobacco smoking. Vitamin D 
is known to affect estradiol, dopamine, and pro-inflammatory cytokine levels, 
besides being involved in the regulation of mechanisms pertaining to hormones like 
glucocorticoids. When vitamin D binds to vitamin D receptors (VDR) present in 
the central nervous system, it is noted to be responsible for the regulation of brain 
neuronal functions. Low 25-hydroxy vitamin D levels are found to have a higher 
incidence of various mood disorders. This review focusses on vitamin D receptors, 
VDR gene mutations, and pathophysiology causing vitamin D deficiency disorders.
Keywords: vitamin D, VDR receptors, mood disorders, deficiency, insufficiency, 
cognition
1. Introduction
Vitamin D is an integral biological substance used to maintain bone health pri-
marily, but it also plays its importance in several other biochemical pathways within 
the human body. Vitamin D, at the end of its metabolizing physiology, gets con-
verted into an active hormone metabolite of vitamin D, i.e., calcitriol (1,25(OH)2 
vitamin D), which binds to vitamin D receptors (VDR). Vitamin D enzymes present 
in the central nervous system are responsible for the regulation of cellular function 
in several tissues located in the body including brain neurons. Vitamin D comes in 
two main forms: the first form is vitamin D2 also known as ergocalciferol which is 
obtained from sources like mushrooms grown in UV light, dietary supplements, 
and fortified food, and the second form of vitamin D is vitamin D3 also known 
as cholecalciferol, obtained from oily fish and fish oil, liver, egg yolk, butter, and 
dietary supplements. Vitamin D2 and D3 are not equal when it comes to raising your 
vitamin D status. Both are effectively absorbed into the bloodstream. However, the 
liver metabolizes them differently. The liver metabolizes vitamin D2 into 25-hydroxy 
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vitamin D2 and vitamin D3 into 25-hydroxy vitamin D3. These two compounds 
are collectively known as calcifediol. The main circulating form of vitamin D is 
Calcifediol. The amount of Calcifediol can be determined by checking its blood 
levels in the body. However, vitamin D2 seems to yield less calcifediol than an equal 
amount of vitamin D3 [1, 2].
Vitamin D deficiency is prevalent worldwide. The knowledge of the causes of 
vitamin D deficiency and community affected by the same causes are prominent, 
and hence, differentiation in the therapy and supplementation of these popula-
tions is focused upon accordingly. Further, in India, the prevalence of vitamin D 
deficiency ranges from 40–90% in all age groups and high-risk groups alike, with 
the majority of study responses reporting 80–90% prevalence as reported by the 
National Center for Biotechnology Information (NCBI), India [3]. Vitamin D 
deficiency contributes to a high disturbance in the health/disease ratio and adds to 
the disease burden of the country [4, 5]. The daily requirement of the human body 
for vitamin D is not fulfilled by the dietary pattern of the Indian population, and 
hence, fortification of various foods with vitamin D is emphasized under the initia-
tives of various national programs [2].
Vitamin D deficiency can be defined as circulating 25(OH) vitamin D levels 
below 20 ng/ml, while vitamin D insufficiency is defined by circulating levels below 
32 ng/ml [3]. Vitamin D receptors are located in the bone, skeletal muscle, immune 
cells, and several other body tissues (including brain, prostate, breast, and colon). 
Deficiency of vitamin D hormone at its receptor site or the enzyme metabolizing 
site causes disturbed cell signalling, further indicating the increased risk of diseases 
like autoimmune diseases, cancer, tuberculosis, cardiovascular diseases, bone 
diseases, neurodegenerative diseases, and mood disorders, specifically discussed in 
this review. Low 25-hydroxyvitamin D levels less than 20 ng/ml are found to have a 
higher incidence of mood disorders consisting of premenstrual syndrome (PMS), 
seasonal affective disorder (SAD), non-specified mood disorder, and major depres-
sive disorder (MDD) [1].
The physiology of vitamin D in the human body involves both synthesizing and 
catabolizing pathways. Vitamin D is either absorbed by dietary intake or is synthe-
sized in the presence of ultraviolet B (UVB) rays ranging from 290 to 310 nm. In the 
epidermal layer of the skin, 7-dehydrocholesterol gets converted into pre-vitamin 
D3 in the presence of UVB rays, which further, under thermal reaction, forms 
vitamin D3 (also known as cholecalciferol). Vitamin D-binding proteins bind to 
vitamin D3, and by circulatory transport this protein-bound vitamin D3 reaches the 
liver, where it is further metabolized into 25(OH) vitamin D (calcifediol) and an 
inert form of vitamin D. Tightly regulated by parathyroid hormone (PTH), 25(OH) 
vitamin D converts into 1,25-dihydroxy vitamin D (also known as calcitriol), which 
is an active hormonal form of vitamin D in the kidneys and other extrarenal tissues. 
This active metabolite binds to vitamin D receptors to regulate the several tissue 
and cellular functions. When vitamin D deficiency occurs due to inadequate intake 
of vitamin D through diet or by application of excessive sun-protective agents, it 
causes dysfunctional regulation of glucocorticoid signalling which is known to 
be implicated in major depressive disorders and various other mood disorders, 
together with other body functioning disorders. It is reported to have elevated levels 
of glucocorticoid (a type of cortisol) for the patients of MDD [1, 6].
This review discusses sources of vitamin D, its association with different types 
of mood disorders in a different population, and its disease processes, together with 
the possible downstream molecular and genetic pathways associated with vitamin 
D deficiency and mood disorders. Further, this review focusses on the vitamin D 
deficiency causing mood disorders to the childbearing mothers and premenstrual 
syndrome to the ladies on the onset of their menses.
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2. Vitamin D status
Vitamin D status is determined by assessing serum levels of 25(OH) vitamin D 
after 3 months of a stable regimen of vitamin D intake. Serum 25(OH) vitamin D is 
used to measure vitamin D status because it is the major circulating form of vita-
min D and the most stable form of vitamin D. The National Health and Nutrition 
Examination Survey (NHANES) III data 8, which used a conservative measure of 
vitamin D deficiency {25(OH) vitamin D} levels <15 ng/mL, has reported 42.4% 
of African American women and 4.2% of white women are deficient in vitamin D 
during their childbearing years [2, 8, 9].
Toxic states (hypervitaminosis D) may occur when 25(OH) vitamin D levels 
supersede 100 ng/ml; however, in a study involving individuals diagnosed with 
multiple sclerosis treated with high doses of vitamin D, there was no evidence of 
toxicity found in individuals with 25(OH) vitamin D levels above 200 ng/ml [1].
3. Dietary recommendations of vitamin D
The dietary recommendations are largely based on bone health and assuming 
a minimal sun exposure of an individual under study. While the safe upper limit is 
set at 4000 international unit/day (IU/d) for healthy adults, for pregnant women, 
doses are higher than 6000 IU/d. Based on limited data from randomized controlled 
trials, some authors suggest that pregnant women can be supplemented with 
1000–2000 IU/d during the second and third trimesters, and a deficiency during 
pregnancy can be treated with daily doses of 4000 IU [5].
4. Synthesizing and metabolizing physiology of vitamin D
Vitamin D is a secosteroid hormone that is either absorbed by dietary intake 
or manufactured by the ultraviolet beam (UVB) rays ranging from 290 to 310 nm 
reaching the epidermis of the skin. In the presence of epidermal 7-dehydrocho-
lesterol, the absorbed vitamin D gets converted into pre-vitamin D3. Within the 
epidermis, a thermal reaction occurs to convert the pre-vitamin D3 into vitamin 
D3 also known as cholecalciferol [10, 11]. Vitamin D3 further, in process, moves 
to bind to the vitamin D-binding plasma proteins. Vitamin D3 is transported via 
vitamin D-binding proteins to the liver where it is metabolized into 25(OH) vitamin 
D (calcifediol) and an inert form of vitamin D. Calcifediol is tightly regulated by 
parathyroid hormone and converts it into 1,25-dihydroxy vitamin D also known 
as calcitriol [1]. Calcitriol is the active form of vitamin D, which binds to VDRs 
in the intestines, bones, and kidney and other extrarenal tissues to enhance the 
absorption of calcium from the intestines, promotes calcium deposition in bones, 
and decreases parathyroid hormone concentrations (PTH) [3, 6]. In the process, 
calcitriol binds to vitamin D receptors, the receptors from the nuclear receptor 
superfamily that regulates the cellular function in several tissues located in the body 
including brain neurons [1].
5. Challenges for estimation of serum vitamin D level
The estimation of calcitriol is very challenging as calcitriol (1,25(OH)2 vitamin D) 
has very short t1/2 and thus does not reflect long-term vitamin D status. Also, it is 
observed that the total 25(OH) vitamin D is the most reliable marker for vitamin D 
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status which measures both vitamin D-binding protein (DBP)-bound and free 
25(OH) vitamin D. In the light of widespread variation in measured results and 
divergent results in response to vitamin D supplementation, there is a need for a 
distinct method for estimation of vitamin D levels. Further, free 25(OH) vitamin D 
levels may vary according to genotype and single nucleotide polymorphisms (SNPs) 
in the DBP gene for which the assays are still not well established [5].
6. Prevalence of vitamin D deficiency
Vitamin D receptors are traced throughout the brain explaining the role 
of vitamin D in psychosomatic disorders, and it was found to have an equivocal call 
for vitamin D deficiency and depression going hand in hand [12].
Vitamin D insufficiency/deficiency is a worldwide problem, affecting all ages and 
races. Optimal 25(OH) vitamin D concentrations for skeletal health are >30 ng/ml. 
Serum 25(OH) vitamin D concentrations are generally lower in blacks than in whites 
and people who avoid exposing them to the sun. The increased use of sunscreens is 
hypothesized to increase the prevalence of vitamin D deficiency. Older adults, as a 
result of hyperparathyroidism related to renal insufficiency, tend to require more 
vitamin D to achieve adequate levels of 25(OH) vitamin D. As a result of the change 
in the definition of adequate concentrations, the prevalence of vitamin D defi-
ciency is higher than previously thought. The prevalence of vitamin D deficiency 
among older men and women living in the United States and Europe ranges from 
40–100%. The National Health and Nutrition Examination Survey from 2000 to 
2004 found that ~25% of men >50 years of age and 30–35% of women >50 years 
of age had 25(OH) vitamin D concentrations <0.001. Two studies performed in 
Colorado and Georgia found that despite reported consumption of more than the 
required daily intake of vitamin D (400–600 IU/d), the prevalence of vitamin D 
insufficiency (defined as <32 ng/mL and < 20 ng/ml, respectively) among commu-
nity-dwelling older adults (mean age, 77.8 and 77.0 years, respectively) ranged  
from 36.7 to 74.0% [3].
7. Vitamin D receptor
7.1 VDR in the brain
Vitamin D receptors are present on the nervous system tissues and cells espe-
cially dopaminergic nerves. In the momentary phase of cerebral development, 
vitamin D may act like a neurosteroid hormone in the areas of neurotransmission, 
neuroprotection, and neuroimmunomodulation. Vitamin D receptors belong to a 
hybrid class of nuclear receptor superfamily, which gets activated by vitamin D, a 
neurosteroid hormone that plays its major role in the nervous system by following 
mechanisms of differentiating, regulating Ca2+ ions, homeostasis, modulation of 
neurotrophins, and release and activation of key brain hormones and enzymes for 
neurotransmitter metabolism. VDR is a large molecular weight protein molecule 
weighing 50–60 kilodaltons, which consists of several functional binding domains, 
specifically and typically for all steroid hormones responsible for ligand binding, 
DNA binding, heterodimerization, nuclear localization, and ligand activation of 
transcriptional factors [13].
VDR detection in the brain tissue has been studied by enzyme-linked immuno-
sorbent assay (ELISA) and immunohistochemistry to understand the localization of 
nuclear ligand binding sites for the transcription of phenotypic characters [14].
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7.1.1 VDR gene location
Two important points of consideration for the production of the active form 
of vitamin D are 1,25(OH)2 vitamin D3, a vitamin D receptor, and an enzyme 1 
α-hydroxylase, which are found in the adult human brain. Identification of both 
the receptor and the enzyme were done in neuronal and glial cells in a regional 
and layer-specific pattern. The equivalent distribution of VDR regions and 
1α-hydroxylase enzyme regions together with their frequent discrete distribution is 
found in layers and subregions of brain tissue [15].
7.1.2 Expression of VDR
Expression of VDR has been documented in tissues, including the brain, heart, skel-
etal muscle, breast, prostate, colon, activated macrophages, skin, and the areas prone 
to tumor expression with any devised mutation. The age factor is known to dominantly 
decrease the VDR expression. Many in vitro studies with human and animal cells have 
observed the expression of not only VDRs but also an enzyme, 1α-hydroxylase, which 
is expressed in most of the body tissues and cells, specifically in the kidneys. Therefore, 
it appears that these cells locally produce the active form of vitamin D by a regulated 
mechanism, in a paracrine fashion, to be used in various cellular and physiological 
functions. This structures the strong biologic basis for the association between serum 
vitamin D concentrations and extra-skeletal physiology [15].
7.1.3 VDR gene mutations
VDR gene mutations have been characterized by altered behavior of VDR null 
mutant mice. A study revealed anxiety-like behavior with decreased exploration 
when the VDR mutant mice were subjected to anxiety evaluation [16]. Another study 
focusing on the investigation of anxiety parameters in VDR mutant mice demon-
strated unaltered spatial memory, olfaction, gustation, and hedonic responses [17].
VDR gene mutation is considered to influence the working of vitamin D hor-
mone, which is essential for the growth and differentiation of a variety of organs, 
including the complete central nervous system. Many studies have suggested the 
crucial role of vitamin D in the brain, inducing many CNS genes. Inhibition of 
brain neurotransmission can be seen by VDR gene mutation causing modulation 
of neuroprotection, neurotrophins release, and activity of key neurotransmitter 
metabolism enzymes [16].
7.1.4 Regulation of normal brain neurotransmitters by normal VDR gene
The active form of vitamin D, i.e., calcitriol has a fast and strong ligand binding 
to their respective receptors located in the bone, brain, and breast tissues, as well as 
in immune cells [6]. The upregulation of transient receptor potential (TRP) vanilloid 
calcium-selective cation channels, such as TRPV5 and TRPV6, is done by positive induc-
tion of vitamin D. Vitamin D regulated channels may express the role of the hormone by 
potential modulation of sensory pathways representing several cellular sensors respond-
ing to temperature, touch, pain, osmolarity, taste, and other stimuli [17].
7.1.5 VDR immunoreactivity
The immunohistochemical study depicted the distribution of the VDR in 
multiple brain regions inclusive of neuronal and glial cells and other regions of the 
substantia nigra in the normal functioning human brain. Further, it also revealed 
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the presence of the VDR and 1α- hydroxylase in the human brain and confirmed the 
cell expression for either the receptor or the activating enzyme in neuronal or glial 
origin [14, 15].
8. Effect of vitamin D on mood and cognition
Vitamin D receptors and the 1α-hydroxylase enzyme have been isolated and 
found in the regions of the cerebral cortex and cerebellum, suggesting the conver-
sion of calcifediol into an active form of vitamin D, i.e., calcitriol in the brain for 
a local cellular response [3, 18]. Several studies discuss the deficiency of vitamin 
D in the body at its targeted ligand binding sites due to less sunlight exposure or 
sun blockage, vitamin D receptor mutation causing phenotypic-conformational 
changes at the ligand binding site, and insufficient vitamin D-fortified diet, all 
causing major or minor mood disorders and illustrate the effectiveness of vitamin D 
or sunlight therapy (phototherapy), gene therapy, or supplemented vitamin D diet 
therapy for the treatment of depression and other mood disorders, demonstrating 
the associations between 25(OH) vitamin D concentrations and mood alone or 
mood and cognition in adults of all ages, including pregnant women, older adults, 
and targeted vitamin D-deficient population globally [3, 10].
9. Mood disorders
Vitamin D receptor mutant gene leads to the translation of mutant mRNA into 
defective vitamin D receptor proteins. Normal VDR is responsible for the regulation 
of glucocorticoid signalling, which, in this case, gets dysfunctional due to vitamin D 
deficiency. Dysfunctional glucocorticoid signalling is majorly implicated in several 
mood disorders like major depressive disorders, seasonal affective disorders, etc. 
Glucocorticoid, a type of cortisol, is seen to be increased in MDD and decreased in 
bone disorders. According to the recent diagnostic and statistical manual of mental 
disorders (DSM-IV), a major depressive disorder is diagnosed or said to be present 
when a person exhibits at least five of the following symptoms during 2 weeks, most 
of the day or nearly every day:
• Depressed mood
• Loss of interest or pleasure in daily activities
• Significant weight loss or gain
• Insomnia or hypersomnia
• Psychomotor agitation or retardation
• Fatigue or loss of energy
• Feelings of worthlessness or inappropriate guilt
• Diminished ability to concentrate or make decisions, problem with attention 
and cognition
• Recurrent suicidal thoughts with or without a plan [1]
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Genes are encoding for vitamin D3, 25-hydroxylase, and 1α-hydroxylase 
(CYP27B1), where CYP27B1 are the enzymes that metabolize vitamin D3 into cal-
ciferol hormones, which is further involved in brain functions. These are expressed 
in neurons and glial cells presenting VDR. Calciferol hormone, being a neuroactive 
compound, regulates the behavioral functions such as anxiety, hyperactivity, and 
depression. Hypovitaminosis is a deficient condition that is found to be associated 
with an increased risk of multiple sclerosis, seasonal affective disorder, schizo-
phrenia, Parkinson’s disease, and Alzheimer’s disease. Vitamin D deficiency could 
also be associated with autism, explained by a piece of indirectly related evidence. 
Furthermore, mood and cognitive performance appear to be dependent on plasma 
vitamin D level to some extent [19].
10. Types of vitamin D-deficient mood disorders
10.1 Seasonal affective disorder
Prevalence of seasonal affective disorder is seen when the vitamin D stored in 
the body are low with prominent seasonal changes. The disorder occurs during a 
particular time of a year where the sun exposure to the skin decreases leading to 
vitamin D deficiency, and the symptoms of the disorder can be resumed spontane-
ously on sun exposure. The individuals suffering from seasonal affective disorder 
have typically reported depression-like symptoms mostly in the winter months, 
where the levels of intensity of sunlight and photoperiod were predominately 
reduced [19–21]. Studies in the United Kingdom estimated the prevalence of SAD 
between 2.4 and 3.5%. The etiology of this disorder has not been fully elucidated, 
but the mechanisms leading to SAD are understood and linked to reduced sun-
light exposure and daylight length. SAD is led via an eye-brain-endocrine system 
pathway or a skin-vitamin D causal pathway. In the mammalian population, the 
first stage of in vivo vitamin D synthesis necessitates the irradiation of skin by 
UVB light, dependently showing the lower vitamin D serum levels in the winter 
months than that in summer months. It has been also postulated that at cellular 
or subcellular levels, vitamin D can directly influence the endocrine system of 
our body via ligand binding on vitamin D receptors present in the entire central 
nervous system of a human body [21]. A prospective, randomized controlled trial 
was conducted in a group of 15 subjects with SAD to postulate the hypothesis of 
the association of vitamin D deficiency and seasonal affective disorder in which 
eight subjects received 100,000 IU of vitamin D and seven subjects received 
phototherapy. The Hamilton Depression Scale, Structured Interview Guide for the 
Hamilton Depression Rating Scale, Seasonal Affective Depression version (SIGH-
SAD), and the SAD-8 depression scale were administered for the evaluation at two 
stages of treatment, i.e., first at onset of treatment and second after one month 
of the therapy. Also, intervention therapy was used to measure serum levels of 
25-hydroxyvitamin D (25-OH D) planned in a gap of 1 week before and after the 
intervention. Improvement in all subjects was seen with the one’s receiving vitamin 
D. Depression scale measure had no significant results for the phototherapy [1, 22].  
Major improvement was seen in both the abovementioned groups, and this 
improvement in 25(OH)D was intertwiningly associated with the improvement in 
depression scale score. Hence, it is evident that vitamin D supplementation has an 
important role in the treatment of SAD [10, 13, 14].
In order to understand the seasonality of mood change, it is integral to understand 
the seasonal changes in photoperiod to hypothesize the most vitamin D-deficient 
mood disorders. Many biological techniques are utilized for detecting photoperiod. 
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For example, initiation of the behavioral changes such as migration patterns and 
breeding behavior is conserved in many species, primates, and humans which are 
evident with changes in season and intensity of sunrays. Further, the scientists 
pointed out that the regulation of circadian phase shift is located in the suprachias-
matic nucleus (SCN) of the hypothalamus. The SCN has been shown to be involved 
in seasonal affective mood disorders. Further it was also presented that the SCN has 
an inhibitory action to the hypothalamic–pituitary–adrenal (HPA) axis and that this 
action can be altered by vitamin D dietary and supplementation restrictions [23].
10.2 Major depressive disorders
Major depressive disorder is a type of depressive disorder that is most likely to 
observe an association between vitamin D deficiency and anxio-depressive dis-
orders. This association can be demonstrated with a parallel comparison between 
the motor and behavioral disorders observed in animal models of depression 
and VDR-KO mice [13]. Several theories are suggesting seasonal mood swings in 
humans. The binding of vitamin D on the ligand binding site of VDR present on the 
hypothalamic core (which plays a crucial role in mood regulation) can be witnessed 
to have a link between several seasonal changes in photoperiod and seasonal mood 
swings. Epidemiological data are coherent with such a cross-linking hypothesis. 
As an instance, the evidence is suggestive that the established low serum 25(OH) 
vitamin D2 concentrations are closely related to the active experience of mood 
disorders in 80 subjects aging 65 years and older. Many studies have demonstrated 
that significant lower serum 25(OH) vitamin D2 and 1,25(OH)2 vitamin D3 concen-
trations are observed in depressive sample subjects than healthy controlled subjects. 
Indirect confirmation was made by studying the association between depression 
and osteoporosis in around 4000 women aged 67 years [15]. Nevertheless, these 
results can also be mitigated and potentially related to functional impairment and 
physical inactivity, both of which reasons to increase with osteoporosis and have an 
independent correlative associated with depression [16].
Various clinical trials support the theory of the efficacy of vitamin D supple-
mentation on mood disorders by varied sources like vitamin D-fortified diet, sun-
soaking, etc. [17]. Improvement in depression scale experiments was noted, and the 
improvements were associated with vitamin D supplementation technique, while 
not much improvement was observed with the phototherapy technique. It is specifi-
cally prescribed to have at least 800 IU daily dose of vitamin D which plays a major 
decisive role in mood disorder case studies [4, 22, 24].
10.3 Premenstrual syndrome
Premenopausal women face one of the most common disorders known as 
premenstrual syndrome. Up to 20% of reproductive-aged women are affected in 
the range of moderate-to-severe premenstrual syndrome and is associated with 
significant levels of mood impairment. Irritability, mood swings, anxiety, depres-
sion, breast tenderness, bloating, and headaches are some of the most common 
symptoms included in PMS. Women are reported to have a depressed mood during 
the last week of the luteal phase which resides within for few days from the onset 
of menses [9]. Many studies have postulated that blood serum calcium levels and 
vitamin D levels are lower in women with PMS and that vitamin D supplementation 
and calcium supplementation may reduce the severity of the symptoms [25].
It is hypothesized that the dysregulation of calciotropic hormone is seen to be a 
major provocative factor in premenstrual syndrome. The severity of the symptoms 
of PMS is directly linked to calcium homeostasis, regulated directly by vitamin D 
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and parathyroid hormone as the key factors. However, low dietary vitamin D intake 
and inhibited induction of parathyroid hormone have been directly associated with 
the development of premenstrual symptoms [8].
10.4 Postpartum depression (PPD)
Vitamin D insufficiency is common in its most vulnerable pregnant popula-
tion, and several studies have demonstrated the association of diminished levels 
of 25(OH) vitamin D with depressive symptoms [4]. Further, the diagnosis of 
low levels of 25(OH) vitamin D in maternal serum during pregnancy is associated 
with a higher incidental risk of postpartum depressive symptoms [26, 27]. Serum 
25(OH) vitamin D levels for pregnant and postpartum women with major depres-
sive episode, beginning within the first 4 weeks after childbirth, can be influenced 
by a multitude of factors like age, race/ethnicity, marital status, type of insurance, 
educational level, feeding type, and others. In addition, the season that accounts 
for the amount and strength of UVB exposure, i.e., photoperiod and vitamin D 
supplementation, also are found to be responsible for the episodes of major depres-
sion [28]. Vitamin D supplementation during pregnancy increases maternal serum 
25(OH) vitamin D levels and thereby ensures higher availability for the offspring 
neuronal development. Vitamin D levels can also be inversely associated with 
infertility parameters, preeclampsia, blood glucose, bacterial vaginosis, primary 
caesarean section, and postpartum depression, but direct correlation is seen in 
pregnancy associated with breast cancer [28, 29].
The core symptoms of PPD are similar to that of any major depressive disorder 
like depressed mood or loss of interest in normal activities, sleep and appetite dis-
turbances, loss of energy, feelings of guilt, and suicidal thoughts. Hence, the diag-
nosis of PPD becomes challenging as the sleep pattern changes and weight changes 
are also often observed in the normal postpartum period. It is further also exhibited 
that the lower maternal 1,25(OH)2 vitamin D levels have been found to be associ-
ated with higher levels of postpartum depressive symptoms as per the Edinburgh 
Postpartum Depression Scale scores. The promising results were observed by only 
one randomized clinical trial wherein the assessment was done by administration of 
high-dose vitamin D therapy in depressed subjects [6, 7].
Following birth in the first few days, the lower levels of 25(OH) vitamin D are 
reported for a greater risk of postnatal depressive symptoms and are also linked to 
serum vitamin D level in the second trimester of pregnancy. Further, the association 
of low 25(OH) vitamin D level was established with a continuous enhancing risk of 
reported level of symptoms that may indicate any one type of mood disturbance. 
Thus, it is confirmed that adequate intake of vitamin D is essential during pregnancy 
not only for the positive impact on the health and development of the offspring 
but also is a way to protect against postpartum mood disturbance in mothers [26]. 
Also, estrogen supplementation and vitamin D therapies have beneficiary effects on 
inflammatory response and related factors in women suffering from PPD [6, 29, 30].
When accounting the cortisol levels and hypothalamic–pituitary–adrenal axis 
reactivity in postpartum women, during the third trimester, maternal cortisol levels 
reach approximately three times that of nonpregnant levels. While the basal levels 
of corticotropin-releasing hormone (CRH), adrenocorticotropic hormone, and 
cortisol are high, the HPA axis reactivity to stressful stimuli is dampened in late 
pregnancy. Furthermore, while the baseline cortisol levels return to normal within a 
couple of days after parturition, the hyporesponsiveness of HPA axis is found to be 
persistent in breastfeeding women [6].
The HPA axis hyperactivation or hypoactivation has always been associated with 
depressive states. It has also been hypothesized that depression during pregnancy 
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and postpartum depression may have different pathogenesis; the first is found to 
be dejected with hyperactivity in the HPA axis and the second being atypical. The 
activity of the HPA axis is usually reduced in seasonal affective disorder, atypical 
depression, and PPD, which could point to a similar pathologic mechanism in all the 
three conditions mentioned. Furthermore, the physiological excess production of 
CRH at the end of pregnancy leads to a transient downregulation of hypothalamic 
CRH postpartum, which could possibly lead to an elevated risk for depression. 
Indeed, the hypothesis of PPD being related to hypoactivation of the HPA axis has 
been substantiated by a number of studies where women with PPD display lower 
baseline or reduced HPA responsiveness than controls, although conflicting data are 
available. In addition, women with a history of PPD appear to have increased levels 
of corticotropin-releasing hormone which further stimulates the dependent cortisol 
response in the experimental conditions of pregnancy. PPD can also be predicted by 
increased stress-induced cortisol levels or CRH levels [6, 20].
Together with SAD, PPD has also been classified, under the depressive states 
characterized by hypoactivation of the HPA axis. Increased serum concentrations 
of biomarkers detecting the inflammatory response, for example, IL-6, a pro-
inflammatory cytokine with a variety of endocrine and metabolic actions, have 
been observed in major depressive conditions. In this, IL-6 interacts with the HPA 
axis, and the interacted complex has significant higher serum levels in women 
with postpartum depressive symptomatology. Conclusively, vitamin D affects 
monoamine functional groups, the HPA axis, and immune responses to stress and 
symptom production [20, 38].
10.5 Aging depressive symptoms
Aging depressive symptoms are noticed for both hypervitaminosis D3 and hypo-
vitaminosis D3, which leads to premature aging of fibroblast growth factor 23 (FGF-
23) that is emerging as a significant mediator/hormone for early aging symptoms, 
and its FGF-23 effects are dominated by vitamin D-mediated excess of calcitriol. 
The early aging phenotypic features include thin skin, intestinal atrophy, spleen 
atrophy, muscle atrophy, weight loss, short life prognosis, osteoporosis, and athero-
sclerosis. There is a tight physiological regulation of 24-hydroxylase, the hormonal 
form of vitamin D3, which can be modulated by physiological serum concentrations 
of calcidiol. This regulation of hormonal form of vitamin D3 explains the develop-
ment of aging depressive symptoms [31]. However, some intoxications occur during 
the early period of synthesis and distribution of vitamin D3 with its substitution/
fortification. After the Second World War, the children in many parts of Europe 
were administered with extremely high oral doses of vitamin D3 and suffered from 
hypercalcemia, nephrocalcinosis, early aging, cardiovascular complications, and 
early death, supporting the possibility of hypothesizing that the hypervitaminosis 
D3 can accelerate aging symptoms [19, 24, 31].
Calciferol hormone insufficiency may accelerate the risk of diseases of CNS. A 
recent study postulated that the hypovitaminosis D3, also famously known as 
vitamin D deficiency, may cause premature or immature aging of cognitive func-
tions. Thus, both a lack and an excess of calciferol hormones enhance aging in major 
dependency [32]. Initial events affect the genome, causing telomere shortening 
or accumulation of DNA damages, which are modulated by the tumor suppressor 
protein, p53. Hormonal forms of vitamin D3 appear to control the basic mechanisms 
of aging and related diseases [19].
The hypothesis of the role of vitamin D in aging is considered based on three 
axial parameters, namely, calciferol hormone serum concentrations, risk of disease, 
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and onset of aging. The former two parameters are seen based on lower and higher 
values, and the latter parameter is seen as the typical or premature onset of aging. It 
is observed that both low and high action of calciferol hormones trigger premature 
aging, including diseases of CNS. Hence, an optimal serum concentration appears 
to delay aging [19].
10.6 Suicidal attempts due to vitamin D deficiency
Significant lower levels of vitamin D are seen in patients with suicidal tenden-
cies than both non-suicidal depressive patients and healthy control individuals. 
Deficiency of vitamin D was found in 58% of cases of all the reported cases of 
suicides, compared to around 30% cases found for the healthy controlled cases and 
the non-suicidal depressed patient cases [33–35].
Accumulating studies indicate that a dysregulated immune system could be a 
contributing factor to depression and possibly specifically to suicidal tendency. 
Direct evidence of causality comes both from animal models, where induction 
of peripheral inflammation is known to lead to depressive changes, and from the 
so-called cytokine-induced depression in humans, where treatment with inter-
ferons (IFN) of patients with hepatitis increases the risk for development of both 
depression and suicidal tendency [32]. Thus, an indirect proportional relationship 
between serum vitamin D concentration and inflammatory cytokines is seen to be 
established, i.e., the lower the vitamin, the higher are the levels of the inflamma-
tory cytokines IL-6 and IL-1β in the blood. The future prospective must be seen to 
compare vitamin D levels between other groups of psychiatric patients and groups 
of patients with personality disorders [7, 34, 36].
10.7 Schizophrenia
A study conducted in the year 2006 on the psychiatric population to understand 
the association between lower plasma levels of 25(OH) vitamin D3 and mood 
disorders revealed that all 82 subjects were suffering from psychiatric disorders. 
Further, 53 patients were suffering from mood disorders, and the remaining 29 
patients were diagnosed with schizophrenia. All these patients were found to have 
low vitamin D3 plasma concentration which confirms the significant association 
of low vitamin D3 plasma concentration with mood disorders and related disease 
symptoms. Additionally, significant hypovitaminosis D was also witnessed in 
mood disorders like major depression, bipolar disorder, and dysthymia than with 
schizophrenia [37]. Also, according to one of the neurodevelopmental hypothesis 
of schizophrenia, it was revealed that the prenatal vitamin D deficiency in a mother 
could be a high-risk factor for schizophrenia in an offspring [24].
10.8 Attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder is an early-onset, chronic, a neurodevel-
opmental disease characterized by attention deficit, hyperactivity, and impulsivity 
mostly in children, affecting nearly 2–18% of children worldwide, and is found to 
be one of the most common psychiatric disorders in childhood stage [32]. Learning 
like basic skills can be affected in childhood and can also cause various psycho-
logical and social interaction problems in children and the adult population. The 
neurotransmitters like dopamine (DA) and noradrenaline (NA) play a crucial role 
in maintaining attention, concentration, motivation, awareness, and cognition. 
With the major role of vitamin D in cerebral function, it might have a direct role 
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in the etiopathogenesis of ADHD in children and young adolescence. Further, 
vitamin D is also responsible for the regulatory synthesis of neurotrophic factors 
such as neurotrophin (NT), NT 3 and NT 4, nerve growth factor (NGF), and glial 
cell line-derived neurotrophic factor (GDNF), known to be significantly involved 
in cell differentiation and survival. Thus, ADHD is etiopathologically connected to 
vitamin D deficiency. In initial years of growth and development of life, vitamin D 
deficiency or extensive insufficiency can be harmful to neuronal development and 
function, resulting in stimulation of neurogenesis [7, 10].
11. Conclusion
To summarize, vitamin D deficiency is associated with several types of mood 
disorders involving various molecular and genetic mechanisms related to vitamin D 
receptors and VDR gene. The VDR gene mutation alters vitamin D binding capac-
ity to vitamin D receptor, preventing vitamin D activation into calcitriol which 
regulates synthesis of neurotrophic factors. Failing to maintain these neurotrophic 
factors in the presence of vitamin D deficiency leads to cerebral dysfunction and 
thereby contributes to mood disorder symptoms. Further, vitamin D deficiency 
is also associated with cognitive reasoning and mind disturbance that trigger off 
mood disorders like major depressive disorders, seasonal affective disorder, suicidal 
tendency, postpartum depression to the childbearing mothers, premenstrual syn-
drome to the ladies on the onset of their menses, ADHD, schizophrenia, and aging 
depressive symptoms. Futures studies and clinical trials can also be structured to 
establish a better understanding of the effects of the vitamin D deficiency on several 
mood disorders, behavioral disorders, and cognition.
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